D
Cytokinetics, Incorporated CYTK
$38.34 $0.290.76% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 85.74M 19.22M 18.47M 3.22M 3.13M
Total Other Revenue -- -- -- -- --
Total Revenue 85.74M 19.22M 18.47M 3.22M 3.13M
Cost of Revenue 390.64M 357.68M 339.41M 330.76M 328.68M
Gross Profit -304.90M -338.46M -320.93M -327.54M -325.54M
SG&A Expenses 242.08M 227.18M 215.31M 197.09M 180.55M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 632.72M 584.86M 554.72M 527.85M 509.22M
Operating Income -546.98M -565.64M -536.25M -524.63M -506.09M
Income Before Tax -606.31M -615.26M -589.53M -576.40M -545.28M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -606.31 -615.26 -589.53 -576.40 -545.28
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -606.31M -615.26M -589.53M -576.40M -545.28M
EBIT -546.98M -565.64M -536.25M -524.63M -506.09M
EBITDA -537.60M -556.14M -526.72M -511.14M -493.16M
EPS Basic -5.12 -5.31 -5.28 -5.39 -5.37
Normalized Basic EPS -3.20 -3.32 -3.30 -3.37 -3.36
EPS Diluted -5.12 -5.31 -5.28 -5.39 -5.37
Normalized Diluted EPS -3.20 -3.32 -3.30 -3.37 -3.36
Average Basic Shares Outstanding 473.71M 463.50M 446.92M 427.92M 406.30M
Average Diluted Shares Outstanding 473.71M 463.50M 446.92M 427.92M 406.30M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --